138 related articles for article (PubMed ID: 4461789)
1. Behavioral effects of central catecholamines: concluding remarks.
Vogt M
J Psychiatr Res; 1974; 11():183-4. PubMed ID: 4461789
[No Abstract] [Full Text] [Related]
2. Symposium on catecholamines and their enzymes in the neuropathology of schizophrenia. Epilogue.
Matthysse S
J Psychiatr Res; 1974; 11():xiii-xvi. PubMed ID: 4618284
[No Abstract] [Full Text] [Related]
3. The dopamine hypothesis of schizophrenia: a review.
Meltzer HY; Stahl SM
Schizophr Bull; 1976; 2(1):19-76. PubMed ID: 779020
[No Abstract] [Full Text] [Related]
4. Brain dopamine and behaviour. A critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs.
Crow TJ; Gillbe C
J Psychiatr Res; 1974; 11():163-72. PubMed ID: 4461788
[No Abstract] [Full Text] [Related]
5. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
[No Abstract] [Full Text] [Related]
6. [Cellular effect of neuroleptics].
Kuschinsky K
Dtsch Med Wochenschr; 1975 Jun; 100(25):1405-8. PubMed ID: 237751
[No Abstract] [Full Text] [Related]
7. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
Matthysse S
Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
[No Abstract] [Full Text] [Related]
8. Biochemical factors in Schizophrenia.
Snyder SH
Hosp Pract; 1977 Oct; 12(10):133-40. PubMed ID: 903124
[TBL] [Abstract][Full Text] [Related]
9. Increased dopamine-receptor sensitivity in schizophrenia.
Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
[TBL] [Abstract][Full Text] [Related]
10. Does dopamine have a role in schizophrenia?
Carlsson A
Biol Psychiatry; 1978 Feb; 13(1):3-21. PubMed ID: 341997
[No Abstract] [Full Text] [Related]
11. Implications of catecholamine systems of the brain in schizophrenia.
Matthysse S
Res Publ Assoc Res Nerv Ment Dis; 1974; 53():305-15. PubMed ID: 4155111
[No Abstract] [Full Text] [Related]
12. The prolactin response in clinical psychiatry.
Gruen PH
Med Clin North Am; 1978 Mar; 62(2):409-24. PubMed ID: 347199
[No Abstract] [Full Text] [Related]
13. Does dopamine play a role in schizophrenia?
Carlsson A
Psychol Med; 1977 Nov; 7(4):583-97. PubMed ID: 22890
[TBL] [Abstract][Full Text] [Related]
14. Dopamine and schizophrenia.
Crow TJ; Johnstone EC; Deakin JF; Longden A
Lancet; 1976 Sep; 2(7985):563-6. PubMed ID: 60635
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: Effect of psychotropic drugs on uptake, retention and biosynthesis of catecholamines as well as on dopamine receptors in isolated synaptosomes.
Kuruma I; Okada T; Kondo Y
Jpn J Pharmacol; 1974; 24(0):s:26. PubMed ID: 4545738
[No Abstract] [Full Text] [Related]
16. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
Lal H; Gianutsos G; Puri SK
Life Sci; 1975 Jul; 17(1):29-34. PubMed ID: 238089
[No Abstract] [Full Text] [Related]
17. Biochemistry and schizophrenia (part IV) the neuroleptics--their mechanism of action: a review of the biochemical literature.
Wyatt RJ
Psychopharmacol Bull; 1976 Jul; 12(3):5-50. PubMed ID: 959470
[No Abstract] [Full Text] [Related]
18. Parkinsonism induced by dopaminergic antagonists.
Hornykiewicz O
Adv Neurol; 1975; 9():155-64. PubMed ID: 1096571
[No Abstract] [Full Text] [Related]
19. [Schizophrenia and dopamine (author's transl)].
Toru M
Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
[No Abstract] [Full Text] [Related]
20. Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour.
Hasselager E; Rolinski Z; Randrup A
Psychopharmacologia; 1972; 24(4):485-95. PubMed ID: 5064290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
